These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6342430)

  • 1. Conditions for the chemical and physical inactivation of the K. Fu. strain of the agent of Creutzfeldt-Jakob disease.
    Walker AS; Inderlied CB; Kingsbury DT
    Am J Public Health; 1983 Jun; 73(6):661-5. PubMed ID: 6342430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent.
    Taguchi F; Tamai Y; Uchida K; Kitajima R; Kojima H; Kawaguchi T; Ohtani Y; Miura S
    Arch Virol; 1991; 119(3-4):297-301. PubMed ID: 1877889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt-Jakob and related agents.
    Kimberlin RH; Walker CA; Millson GC; Taylor DM; Robertson PA; Tomlinson AH; Dickinson AG
    J Neurol Sci; 1983 Jun; 59(3):355-69. PubMed ID: 6308174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease).
    Gajdusek DC; Gibbs CJ; Asher DM; Brown P; Diwan A; Hoffman P; Nemo G; Rohwer R; White L
    N Engl J Med; 1977 Dec; 297(23):1253-8. PubMed ID: 335248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical disinfection of Creutzfeldt-Jakob disease virus.
    Brown P; Gibbs CJ; Amyx HL; Kingsbury DT; Rohwer RG; Sulima MP; Gajdusek DC
    N Engl J Med; 1982 May; 306(21):1279-82. PubMed ID: 7040968
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of a novel agent possessing resistance to moist heat and disinfectants: parallels with Creutzfeldt-Jakob agent.
    Dyas AC; Burdon DW
    J Hosp Infect; 1990 Apr; 15(3):265-72. PubMed ID: 1971633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Creutzfeldt Jakob disease. Recommended precautions for patient management and diagnostic procedures (author's transl)].
    Brown P; Cathala F; Gajdusek DC
    Rev Neurol (Paris); 1978 Apr; 134(4):277-86. PubMed ID: 364589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel replicating agent isolated from the human intestinal tract having characteristics shared with Creutzfeldt-Jakob and related agents.
    Burdon DW
    J Med Microbiol; 1989 Jun; 29(2):145-57. PubMed ID: 2659797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical methods for chemical inactivation of Creutzfeldt-Jakob disease pathogen.
    Tateishi J; Tashima T; Kitamoto T
    Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1909414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for an unconventional virus in mouse-adapted Creutzfeldt-Jakob disease.
    Kingsbury DT; Smeltzer DA; Amyx HL; Gibbs CJ; Gajdusek DC
    Infect Immun; 1982 Sep; 37(3):1050-3. PubMed ID: 6752018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the Creutzfeldt-Jakob disease agent.
    Tamai Y; Taguchi F; Miura S
    Ann Neurol; 1988 Sep; 24(3):466-7. PubMed ID: 3067657
    [No Abstract]   [Full Text] [Related]  

  • 12. Inactivation of TSE agents: safety of blood and blood-derived products.
    Taylor DM
    Transfus Clin Biol; 2003 Feb; 10(1):23-5. PubMed ID: 12668184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of blood on the antiviral activity of sodium hypochlorite, a phenolic, and a quaternary ammonium compound.
    Weber DJ; Barbee SL; Sobsey MD; Rutala WA
    Infect Control Hosp Epidemiol; 1999 Dec; 20(12):821-7. PubMed ID: 10614606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decontamination efficacy of sodium hypochlorite solutions for poliovirus.
    Orel I; Graf H; Riou P
    Biologicals; 2020 Sep; 67():75-80. PubMed ID: 32807609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of transmissible degenerative encephalopathy agents: A review.
    Taylor DM
    Vet J; 2000 Jan; 159(1):10-7. PubMed ID: 10640408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue.
    Brown P; Rohwer RG; Gajdusek DC
    J Infect Dis; 1986 Jun; 153(6):1145-8. PubMed ID: 3084671
    [No Abstract]   [Full Text] [Related]  

  • 17. Growth and spread of causative agent of Creutzfeldt-Jakob disease in intraperitoneally infected mice.
    Chino F; Ohkawa T
    Jpn J Med Sci Biol; 1990 Dec; 43(6):197-208. PubMed ID: 2101136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Jakob-Creutzfeld disease--intra vitam diagnosis?].
    Pencz A; Distelmeier PM; Gulotta F; Schlake W
    Dtsch Med Wochenschr; 1987 Aug; 112(33):1257-60. PubMed ID: 3301262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of the Creutzfeldt-Jakob disease agent.
    Tateishi J; Tashima T; Kitamoto T
    Ann Neurol; 1988 Sep; 24(3):466. PubMed ID: 3067656
    [No Abstract]   [Full Text] [Related]  

  • 20. [Safety measures for handling laboratory specimen and patients with Creutzfeldt-Jakob disease].
    Van Everbroeck B; Pals P; Cras P
    Ned Tijdschr Geneeskd; 1999 Jul; 143(29):1511-4. PubMed ID: 10443273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.